2018
Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Njei B, Sharma P, McCarty TR, Singh M, Haque L, Aslanian HR, Jamidar P, Muniraj T. Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2018, 47: 1142-1149. PMID: 30134357, DOI: 10.1097/mpa.0000000000001143.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisIncidence risk ratioCholangiopancreatography pancreatitisCannabis useRisk of PEPEndoscopic retrograde cholangiopancreatography pancreatitisUS Nationwide Inpatient SampleRate of PEPShorter hospital stayNationwide Inpatient SampleNinth Edition codesImpact of cannabisPoisson regression modelsHospital deathHospital stayIndependent predictorsEdition codesRisk ratioInpatient SampleInternational ClassificationMultivariate analysisPancreatitisPatientsCannabisSignificant increase
2015
Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Rustagi T, Njei B. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2015, 44: 859-867. PMID: 26168316, PMCID: PMC4824288, DOI: 10.1097/mpa.0000000000000326.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisNonsteroidal anti-inflammatory drugsAnti-inflammatory drugsCholangiopancreatography pancreatitisRectal administrationIncidence of PEPRisk of PEPPreventing Post-Endoscopic Retrograde Cholangiopancreatography PancreatitisPancreatic duct injectionOddi dysfunctionSubgroup analysisDuct injectionPatientsTreatment typeRelevant studiesERCPPancreatitisSignificant reductionAdministrationDrugsEfficacySignificant benefitsRiskPlaceboSphincter